NASDAQ:TNGX • US87583X1090
ChartMill assigns a Buy % Consensus number of 86% to TNGX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-06 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-04 | Stifel | Initiate | Buy |
| 2025-11-18 | Wolfe Research | Initiate | Peer Perform |
| 2025-11-18 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-10-24 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-08-06 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-11 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Guggenheim | Maintains | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-07-17 | Jefferies | Initiate | Buy |
| 2024-07-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-07-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-24 | Guggenheim | Maintains | Buy -> Buy |
| 2024-05-24 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-23 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-04 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-03-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-12 | Piper Sandler | Initiate | Overweight |
| 2023-12-08 | B. Riley Securities | Initiate | Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
16 analysts have analysed TNGX and the average price target is 13.64 USD. This implies a price increase of 5.76% is expected in the next year compared to the current price of 12.9.
The consensus rating for TANGO THERAPEUTICS INC (TNGX) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.